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Postoperative acute kidney injury defined by RIFLE criteria predicts
early health outcome and long-term survival in patients undergoing
redo coronary artery bypass graft surgery
Mustafa Zakkar, PhD, MRCS, Vito D. Bruno, PhD, MD, Gustavo Guida, MD,
Gianni D. Angelini, MD, MCh, FRCS, FMedSci, Pierpaulo Chivasso, MD,
M. Sadeeh Suleiman, PhD, DSc, FIACS, FSB, Alan J. Bryan, FRCS, and
Raimondo Ascione, FRCS, MD, ChM
ABSTRACT
Objective: To investigate the impact of postoperative acute kidney injury (AKI)
on early health outcome and on long-term survival in patients undergoing redo
coronary artery bypass grafting (CABG).
Methods: We performed a Cox analysis with 398 consecutive patients
undergoing redo CABG over a median follow-up of 7 years (interquartile range,
4-12.2 years). Renal function was assessed using baseline and peak postoperative
levels of serum creatinine. AKI was defined according to the risk, injury, failure,
loss, and end-stage (RIFLE) criteria. Health outcome measures included the rate
of in-hospital AKI and all-cause 30-day and long-term mortality, using data from
the United Kingdom’s Office of National Statistics. Propensity score matching, as
well as logistic regression analyses, were used. The impact of postoperative AKI
at different time points was related to survival.
Results: In patients with redo CABG, the occurrence of postoperative AKI was
associated with in-hospital mortality (odds ratio [OR], 3.74; 95% confidence
interval [CI], 1.3 to 10.5; P < .01], high Euroscore (OR, 1.27; 95% CI,
1.07-1.52; P< .01), use of IABP (OR, 6.9; 95% CI, 2.24-20.3; P< .01), and
reduced long-term survival (hazard ratio [HR], 2.42; 95% CI, 1.63-3.6;
P ¼ .01). Overall survival at 5 and 10 years was lower in AKI patients with AKI
compared with those without AKI (64% vs 85% at 5 years; 51% vs 68% at
10 years). On 1:1 propensity scorematching analysis, postoperativeAKIwas inde-
pendently associatedwith reduced long term survival (HR, 2.8; 95%CI, 1.15-6.7).
Conclusions: In patients undergoing redo CABG, the occurrence of postoperative
AKI is associated with increased 30-day mortality and major complications and
with reduced long-term survival. (J Thorac Cardiovasc Surg 2016;152:235-42)
CONSORT diagram of patients undergoing redo CABG
between 1998 and 2014, showing exclusion criteria,
rate of AKI, and 1:1 propensity score matching.
Central Message
The occurrence of postoperative AKI following
redo CABG surgery is associated with
increased early and long-term mortality. This
finding might help clinical decision making
and guide patient consent.
Perspective
Our findings improve the understanding of the
impact of postoperative AKI on short-term
health outcome and on long-term survival in
patients undergoing redo CABG. This is of po-
tential benefit to surgeons and intensivists man-
aging redo CABG cases during their hospital
stay, as well as to patients who might benefit
from a more informative consent process.
See Editorial Commentary page 243.
In developed countries, the number of patients undergoing any
redo cardiac surgery procedures across all surgical categories
is on the rise.1This increase canbe attributed tovarious factors,
including prolonged overall longevity, improved survival
following cardiac surgery, progression of native coronary
disease and/or limited long-term patency rate of saphenous
vein grafts, an increasing number of patients requiring pallia-
tion for complex congenital malformations, and the limited
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PERIOPERATIVE MANAGEMENT: CARDIAC: KIDNEY INJURY
long-termdurability of bioprosthetic valves.2-5 Conversely, the
incidence of patients requiring redo coronary artery bypass
grafting (CABG) has been declining gradually over time6,7;
however, evidence suggests that despite refinements in
surgical, perfusion, and anesthetic techniques, redo CABG is
still associated with increased in-hospital mortality.6,7
Acute kidney injury (AKI) is recognized as an independent
risk factor for adverse outcomes in patients undergoing car-
diac surgery.8-11 Introduction of the risk, injury, failure,
loss, and end-stage (RIFLE) criteria has standardized the defi-
nition of AKI, allowing more objective comparisons among
different studies.12 The combination of redo CABG and
occurrence of postoperative AKI is potentially lethal, yet no
data are available on the rate of postoperativeAKI defined ac-
cording to the RIFLE criteria in patients undergoing redo
CABG, or on the impact of postoperative AKI on early health
outcomes and long-term survival in these patients.7,13,14
The aim of this study was to evaluate the impact of
postoperative AKI on early health outcomes as well as
long-term survival in a consecutive series of patients
undergoing redo CABG.
MATERIALS AND METHODS
We conducted a retrospective analysis of prospectively collected data
for all patients undergoing redo CABG from our institutional database
registry. These data are prospectively collected, validated, and stored by
a dedicated independent team as part of the United Kingdom’s National
Registry. The study protocol was in compliance with the local Institutional
Clinical Audit Review Board and received full approval; the need for
patient consent was waived.
Patient Selection
A Consolidated Standards of Reporting Trials flow diagram for patient
selection is shown in Figure 1. Data from 15,436 consecutive patients
undergoing isolated CABG between 1998 and 2014 were evaluated, of
whom 398 patients were identified as having undergone redo CABG. Of
these, 18 were excluded from final analysis due to either the use of
preoperative dialysis or the incompleteness of postoperative AKI data.
The remaining 380 patients who underwent redo CABG were included
in the analysis and were divided into 2 groups based on the occurrence
of postoperative AKI.
Definition of AKI
All patients had baseline serum creatinine (SCr) and estimated
glomerular filtration rate (eGFR) values derived from our institutional
database registry. AKI was defined according to the RIFLE criteria by the
change in SCr from baseline to postoperative values. Based on a previous
report,13 we opted to use the highest SCr value (ie, poorest measurement)
recorded during postoperative recovery to comparewith the baseline value.
According to the RIFLE criteria, SCr must be increased by at least 50%
from baseline value for a classification as AKI.12
Data Collection, Definitions, and Clinical
Management
Baseline, intraoperative, and postoperative data collection and recording
of health outcomes were done prospectively out at our institution according
to the standards of themandatoryNational Cardiac Surgery Audit. Baseline
data collection included a detailed risk profile, symptomstatus, pastmedical
history, and baseline renal function, including SCr and eGFR values as
calculated from theModification of Diet in RenalDisease equation. Postop-
erative peak SCr values were obtained manually from medical records, and
eGFR values were calculated accordingly. Intraoperative and postoperative
clinical management was maintained according to strict predefined proto-
cols. Detailed evaluation of baseline computed tomography (CT) angiog-
raphy results, along with evaluation of previous CABG surgery,
distribution of native coronary disease, as well as patency and/or occlusion
of bypass grafts, to inform the surgical approach. Surgical, anesthesia,
perfusion, and organ protection techniques were applied as reported previ-
ously by our group.15,16
To minimize the risk of injury at reentry, preoperative CT angiography
scanning was used at the surgeon’s discretion to ascertain the anatomic
relationship of any patent grafts with the planned entry route. Other factors
considered included a ‘‘no touch’’ technique for blocked vein grafts, along
with isolation of any patent left internal mammary artery on a vessel loop,
followed by soft clamping of previous cardioplegia. Occasionally, when the
baseline CT angiography scan indicated a close anatomic relationship
between the heart and/or any patent grafts with the sternum,
femoro-femoral cardiopulmonary bypass (CPB) before chest reentry was
established, again based on surgeon preference. Similarly, the use of
off-pump surgery was based on surgeon preference.
Intraoperative data collection included use of CPB, cross-clamp time,
perfusion time, use of off-pump coronary surgery, preoperative use of an
intra-aortic balloon pump (IABP), and degree of procedural urgency,
defined as elective (admitted from home) or urgent (admitted as an
in-hospital transfer after CT angiography owing to clinical factors or the
severity of coronary disease). Early postoperative data collection included
30-day mortality, occurrence of postoperative AKI, all postoperative
complications, and length of hospital stay.
Patient management after surgery was provided according to our
established protocols. Patients with no pending clinical issues after surgery
were discharged directly to home with a visit to our outpatient clinic
scheduled for 6 weeks after discharge. If clinically necessary, this visit
was repeated at 3 months. At this stage, patients exhibiting complete
surgical recovery were discharged back to the care of the referring
Abbreviations and Acronyms
AKI ¼ acute kidney injury
ARF ¼ acute renal failure
CABG ¼ coronary artery bypass grafting
CCS ¼ Canadian Cardiovascular Society
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
CT ¼ computed tomography
eGFR ¼ estimated glomerular filtration rate
HR ¼ hazard ratio
IABP ¼ intra-arterial balloon pump
LVEF ¼ left ventricular ejection fraction
OR ¼ odds ratio
RIFLE ¼ risk, injury, failure, loss, and end-stage
SCr ¼ serum creatinine
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cardiologist and general practitioner. Patients developing postoperative
wound healing issues were referred to our wound clinic, with repeated
long-term visits until complete recovery before discharge to the general
practitioner. Patients developing noncardiac single-organ renal, respiratory,
and/or neurologic dysfunction/failure were treated at our center until com-
plete recovery and referred to a specialist center for further management
beyond the 30-day cutoff. Late survival data after discharge were obtained
from the National Health Service’s tracking service, with the latest data ob-
tained on February 21, 2015.
Statistical Analysis
Data are presented as mean  SD for continuous variables and as
number and percentage for dichotomous variables. Continuous variables
were tested for normality using the Shapiro-Wilk test and then compared
between groups with the unpaired Student t test if normally distributed
or the Mann-Whitney U test if non-normally distributed. In cases of
dichotomous variables, the Pearson c2 or Fisher exact test was used as
appropriate.
Univariate analyses for in-hospital and long-termmortality were carried
out, and the predictors thus obtained were subsequently tested in a
multivariable logistic regression model. The model was built using the
following variables: AKI after surgery, emergency procedure, use of
on-pump surgery, preoperative use of nitrates, evidence of preoperative
cardiogenic shock, use of an IABP, evidence of previous myocardial
infarction, Euroscore, and reduced left ventricular ejection fraction
(LVEF). A stepwise approach was used and was confirmed by backward
and forward methods. The significance within the final models was
evaluated with the Wald test, whereas the strength of the association of
each variable with postoperative death was estimated by calculating the
odds ratio (OR) and 95% confidence interval (CI). The model was
calibrated using the Hosmer-Lemeshow goodness-of-fit test. Model
discrimination was evaluated using the area under the receiver operating
characteristic curve.
The event-free survival rate was estimated for the patients who
developed postoperative AKI and those who did not using the
Kaplan-Meier method and then compared with the log-rank test. A Cox
proportional hazard model (with Breslow likelihood approximation) was
developed to address the predictors for long-term survival.
To further adjust for patient selection and preoperative characteristics, a
propensity score-matched analysis was conducted. The group of patients
who did not develop AKI was 1:1 matched to the group of patients who
did develop AKI using the following variables: age (years), sex, basal
SCr, emergency surgery, LVEFcategory,NewYorkHeartAssociation class,
CanadianCardiovascular Society (CCS) class, and Euroscore. This resulted
in 2 paired groups with 60 patients each, designated AKI and non-AKI. Af-
termatching, the 2 groupswere comparedusing the paired t test orWilcoxon
test for continuous variables and the McNemar or Fisher exact test for
categorical variables. A conditional logistic regression model was also
developed to identify predictors of in-hospital mortality, including the
same variables used for the nonmatched unconditional logistic regression.
Event-free survival rates were estimated by the Kaplan-Meier method and
subsequently comparedwith the log-rank test even in this subset ofmatched
patients. A Cox proportional hazard model was developed, stratifying for
matching index. Missing values were addressed via multiple imputation.
All tests were 2-sided, with an a level set at 0.05 for statistical significance.
Clinical data were recorded and subsequently tabulated with Excel
(Microsoft, Redmond,Wash). All statistical analyses were conducted using
R version 3.0.2 (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Overall In-Hospital and 30-Day Clinical Outcomes
The distributions of baseline patient characteristics for
the overall population and for the propensity score–matched
population are presented in Table 1. The total study cohort
of 380 patients comprised 323 males (85%) and 57 females
(15%), with an overall mean age of 66.9  9 years. Of the
380 patients recruited, 237 (62.3%) underwent redo CABG
using CPB and cardioplegic arrest, whereas the remaining
143 (37.6%) underwent beating heart off-pump redo
CABG.
Overall postoperative outcomes are presented in Table 2.
The 30-day mortality was 4.7%, with 18 deaths, including
11 due to multiorgan failure/sepsis, 5 due to cardiogenic
shock, and 2 due to permanent stroke. For cause-and-
effect considerations, the 18 patients experiencing early
death also sustained the following postoperative
complications: 7 cases of acute renal failure (ARF)
requiring dialysis, 7 cases of cardiogenic shock, 2 cases
of permanent stroke, 4 cases of respiratory failure requiring
tracheostomy, and 1 case of deep mediastinitis. In addition,
5 patients (1.4%) sustained postoperative stroke, 8 patients
(3.7%) needed surgical reexploration for bleeding, and 27
patients (7.1%) required an IABP. The overall average post-
operative in-hospital length of stay was 9.17  8.0 days.
Occurrence of In-Hospital AKI and Impact on
30-Day Health Outcomes
Sixty of the 380 patients (15.8%) developed
postoperative AKI according to the following RIFLE
FIGURE 1. CONSORT (Consolidated Standards of Reporting Trials)
diagram of patients undergoing redo CABG between 1998 and 2014,
showing exclusion criteria, rate of AKI, and 1:1 propensity score matching.
CABG, Coronary artery bypass grafting; AKI, acute kidney injury.
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criteria classes: R, n¼ 39 (65%); I, n¼ 15 (25%); F, n¼ 6
(10%). For the overall population, the AKI group had a
higher average incidence of moderate to poor LVEF,
higher angina class, reduced eGFR (50% vs 25.6%;
P < .01), higher SCr level (117  35.9 mmol/L vs
100  29 mmol/L; P<.01) and higher Euroscore (Tables
1 and 2). There were no baseline differences between the
2 groups following 1:1 propensity score matching, however.
In the overall cohort, the occurrence of in-hospital
AKI was associated with increased 30-day mortality












(n ¼ 60) P value
Age, yr, mean  SD 66.9  9 68.7  8.9 66.6  8.9 .08 68.7  8.9 66.9  9.4 .31
Female sex, n (%) 57 (15) 8 (13.3) 49 (15.3) .89 8 (13.3) 6 (10) .77
BMI, kg/m2, mean  SD 27.2  4.4 26.1  4.6 27.4  4.3 .07 26.2  4.7 27.4  4.7 .15
LVEF, n (%) .04 .65
Good 247 (65.1) 34 (56.7) 213 (66) 34 (56.7) 35 (58.3)
Moderate 109 (28.7) 18 (30) 91 (28.4) 18 (30) 18 (30)
Poor 24 (6.31) 8 (13.3) 16 (8) 8 (13.3) 7 (11.7)
Diabetes, n (%) .54 .90
No 294 (77.4) 46 (76.7) 248 (77.5) 46 (76.7) 47 (78.3)
Diet 16 (4.2) 3 (5) 13 (4.1) 3 (5) 2 (3.3)
Oral treatment 45 (11.8) 5 (8.3) 40 (12.5) 5 (8.3) 7 (11.7)
Insulin treatment 25 (6.5) 6 (10) 19 (5.9) 6 (10) 4 (6.7)
Hypertension, n (%) 271 (71.3) 51 (85) 220 (68.8) .06 41 (68.3) 38 (63.3) .23
Previous CVA, n (%) 49 (12.8) 10 (16.7) 39 (12.2) .60 10 (16.7) 8 (13.3) .12
PVD, n (%) 78 (20.5) 16 (26.7) 62 (19.4) .19 16 (26.7) 13 (21.7) .64
COPD, n (%) 57 (15) 12 (20) 45 (14.1) .23 12 (20) 8 (13.3) .45
Smoking, n (%) .63 .87
Never smoked 101 (26.6) 16 (26.7) 85 (26.5) 16 (26.7) 16 (26.7)
Ex-smoker 246 (64.7) 39 (65) 207 (64.7) 39 (65) 36 (60)
Current smoker 33 (8.6) 5 (8.3) 28 (8.8) 5 (8.3) 8 (13.3)
NYHA class, n (%) .06 .37
Class I 63 (16.6) 7 (11.7) 56 (17.5) 7 (11.7) 5 (8.3)
Class II 149 (39.2) 17 (28.3) 132 (41.2) 17 (28.3) 20 (33.3)
Class III 148 (38.9) 32 (53.3) 116 (36.2) 32 (53.3) 32 (53.3)
Class IV 20 (5.2) 4 (6.7) 16 (5) 4 (6.7) 3 (5)
CCS class, n (%) <.01 .78
Class 0 41 (10.8) 10 (16.7) 31 (9.7) 10 (16.7) 10 (16.9)
Class I 25 (6.6) 10 (16.7) 15 (4.7) 10 (16.7) 4 (6.8)
Class II 82 (21.6) 11 (18.3) 71 (22.2) 11 (18.3) 10 (16.9)
Class III 132 (34.7) 16 (26.7) 117 (36.6) 16 (26.7) 15 (25.4)
Class IV 99 (26) 13 (21.7) 86 (26.9) 13 (21.7) 20 (33.9)
Euroscore II, mean  SD 5.11  4.03 6.12  3.6 4.91  3.8 <.01 6.12  3.6 5.91  3.4 .12
Left main disease, n (%) 89 (23.4) 16 (26.7) 73 (22.8) .51 16 (26.7) 14 (23.3) .82
Atrial fibrillation, n (%) 29 (7.6) 7 (11.7) 22 (6.9) .19 7 (11.7) 9 (15) .79
Reduced eGFR, n (%) 112 (29.5) 30 (50) 82 (25.6) <.01 30 (50) 30 (50) 1
Baseline SCr, mmol/L, mean  SD 102.8  30.8 117  35.9 100  29 <.01 117  35.9 114  41.8 .26
Peak SCr, mmol/L, mean  SD 133.3  78.8 248  121 111  39.8 <.01 248  121 120  52.7 <.01
Urgency, n (%) .34 .91
Elective 235 (61.8) 33 (55) 202 (63.1) 33 (55) 34 (56.7)
Urgent 134 (35.2) 24 (40) 110 (34.4) 24 (40) 22 (36.7)
Emergency 10 (2.6) 3 (5) 7 (2.2) 3 (5) 4 (6.7)
Salvage 1 (0.26) 0 1 (0.3) 0 0
Off-pump, n (%) 143 (37.6) 18 (30) 125 (39.1) .23 18 (30) 24 (40) .46
Number of grafts, mean  SD 2.22  0.8 2.21  0.88 2.33  0.9 .26 2.2  0.9 2.2  20.9 .30
AKI, Acute kidney injury; SD, standard deviation; BMI, body mass index; LVEF, left ventricular ejection fraction; CVA, cerebrovascular accident; PVD, peripheral vascular
disease; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society; eGFR, estimated glomerular filtration
rate; SCr, serum creatinine.
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(13.3% vs 3.1% for no AKI; P< .01), reoperation for
bleeding (6.7% vs 1.3%; P ¼ .03), and prolonged hospital
stay (13.6  12.8 days vs 8.35  6.4 days; P<.01). After
propensity score matching, a between-group difference in
mortality of approximately 8% remained, although this
did not reach statistical significance. Similarly, the AKI
group had an average of 3-day longer hospital, although
again this difference did not reach statistical significance.
With regard to postoperative renal function, the occurrence
of AKI was associated with a higher postoperative peak SCr
value in the AKI group in both the overall and the matched
study cohorts. In addition, 11 of 60 patients in the AKI
group (18.3%) developed complete ARF requiring renal
replacement therapy, whereas there was no occurrence of
ARF in the non-AKI group. Of note, the 11 cases of ARF
occurred in 6 of the 6 patients with class F AKI and in 5
of the 15 patients with class I AKI.
Univariate analyses identified AKI, preoperative nitrate
use, Euroscore, emergency operation, and preoperative
IABP use as associated with increased 30-day mortality.
However, our multivariate logistic regression analysis
suggested that AKI (OR, 3.74; 95% CI, 1.3 to 10.5;
P < .01), Euroscore (OR, 1.27; 95% CI, 1.07-1.52;
P < .01), and preoperative IABP (OR, 6.9; 95% CI,
2.24-20.3; P<.01) were independent predictors of 30-day
mortality in patients undergoing redo CABG (Table 3).
After propensity score matching, only the use of IABP
remained as an independent predictor of 30-day mortality
(OR, 7.52; 95% CI, 2.08-27.14; P<.01).
Occurrence of In-Hospital AKI and Impact on
Long-Term Survival
The median duration of follow-up was 7 years (interquar-
tile range, 4-12.2 years). Late survival in the AKI and
non-AKI groups is shown in Figure 2. The 1-year
follow-up found an actuarial overall survival of 90.3% after
redo CABG (80% for AKI vs 93% for non-AKI). Overall
5-year survival was 79% (64% for AKI vs 85% for
non-AKI), and 10-year survival was 64% (51% for AKI
vs 68% for non-AKI). Table 4 presents results from our
Cox proportional hazard model identifying postoperative
AKI, age, IABP use, and previous myocardial infarction
as independent predictors of long-term mortality. After
propensity score matching, only postoperative AKI
and IABP use remained as independent predictors of
long-termmortality, and the survival rate remained different
between the 2 groups (P<.01, log-rank test).
DISCUSSION
Cardiac reoperation remains an integral part of daily car-
diac surgery practice, accounting for 5% to 8% of the entire
surgical workload.6,17 These procedures are technically
challenging because of the recognized difficulty in
gaining access to the heart owing to adhesions, scarring,
fibrosis, or calcifications at the operative site, leading to
prolonged operating times and high rates of early
mortality and postoperative complications.
Redo CABG procedures still account for 2.5% to 4% of
the surgical coronary practice in developed countries, with
associated mortality as high as 4% to 5%6 despite advances
in surgical techniques. Sabik and colleagues7 evaluated the
outcomes of 21,568 CABG procedures, of which 4518 were
reoperations and reported in-hospital mortality of 4.3% for
a first redo, 5.1% for a second redo, and 6.4% for third or
subsequent redos. These figures are in agreement with the
findings published by Ghanta and colleagues,6 who recently
reported the outcomes of 1.5 million isolated CABG oper-
ations (including 72,322 redo CABGs) from the Society
of Thoracic Surgeons’ adult cardiac surgery database.
Nonetheless, very little data are available in the literature
on the impact of patient characteristics and postoperative
complications on early health outcomes and long-term
mortality in patients undergoing redo CABG taking into
account the RIFLE criteria.












(n ¼ 60) P value
Periprocedural mortality, n (%) 18 (4.7) 8 (13.3) 10 (3.1) <.01 8 (13.3) 3 (5) .22
CVA, n (%) 5 (1.4) 2 (3.3) 3 (0.9) .17 2 (3.3) 2 (3.3) 1
Reoperation for bleeding, n (%) 8 (3.7) 4 (6.7) 4 (1.2) .02 4 (6.6) 2 (3.3) .37
IABP use, n (%) 27 (7.1) 9 (15) 18 (33.3) .02 9 (15) 11 (18.3) .8
Length of stay, d, mean  SD 9.17  8.0 13.6  12.8 8.3  6.4 <.01 13.6  12.8 10.7  10.5 .06
AKI, Acute kidney injury; CVA, cerebrovascular accident; IABP, intra-aortic balloon pump; SD, standard deviation.
TABLE 3. Independent predictors of 30-day mortality before and
after propensity matching
Variable OR 95% CI P value
Overall population
AKI 3.74 1.3-10.5 .01
Euroscore 1.27 1.07-1.52 <.01
Use of IABP 6.9 2.24-20.29 <.01
Propensity score–matched population
Use of IABP 7.52 2.08-27.14 <.01
OR, Odds ratio; CI, confidence interval; AKI, acute kidney injury; IABP, intra-aortic
balloon pump.
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Our main finding in the present study is the association
between postoperative AKI and increased 30-day mortality
and other major postoperative complications, as well as
long-term mortality. Previous studies have confirmed that
in redo CABG, a high baseline Euroscore and IABP use
are also associated with 30-day mortality, and that advanced
patient age and CCS class3 are independent predictors of
all-cause long-term mortality.2,6,7
For the purpose of this study, we defined AKI based on
the RIFLE criteria, which have been widely validated and
accepted as a standard methodology for qualifying and
quantifying AKI after cardiac surgery. Strong associations
have been reported between AKI as defined by the RIFLE
criteria and outcomes in patients undergoing cardiac
surgery.11,13,15,16,18-20 Some studies have suggested an
association between AKI as defined by the RIFLE criteria
and late health outcome as well, although in patients
undergoing first-time cardiac surgery.14,20 In a wide
analysis of 2973 patients undergoing any cardiothoracic
surgery, Hobson and colleagues21 reported that the risk of
death associated with AKI defined by the RIFLE criteria
after cardiothoracic surgery remains high for 10 years
regardless of the presence of other risk factors. The hazard
ratio (HR) for the subgroup of patients undergoing first-time
CABG was 1.28 (95% CI, 1.05-1.54; P ¼ .01). Unfortu-
nately, however, those authors did not report on redo
CABG. Another recent study evaluating the impact of
AKI by the RIFLE criteria in patients undergoing
first-time CABG compared AKI and non-AKI groups using
a propensity score matched analysis and found higher
mortality for the AKI group.11 The HR for AKI was 1.8
(95% CI, 1.5-2.16; P< .001) before matching and 1.52
(95% CI, 1.19-1.93; P< .01) after matching. That study
also did not report on patients undergoing redo CABG,
however.
In the present study, the incidence of postoperative AKI
by the RIFLE criteria was 15.8%. Bove and colleagues,14
in an observational study of 5068 cardiac surgeries
FIGURE 2. Impact of AKI on 10-year survival. The log-rank test shows a significant difference between the 2 groups. AKI, Acute kidney injury.
TABLE 4. Cox proportional hazard model for mortality
Variable (reference level)
Overall population
HR (95% CI) P value
Propensity score–matched population
HR (95% CI) P value
AKI* 2.42 (1.63-3.6) <.01 2.8 (1.15-6.7) .02
Age 1.03 (1.01-1.05) <.01
Use of IABP 1.66 (0.98-2.8) .059 5.7 (1.04-31.1) .04
Previous MI 1.4 (0.99-1.97) .055
HR, Hazard ratio; CI, confidence interval; AKI, acute kidney injury; IABP, intra-aortic balloon pump; MI, myocardial infarction. *Defined as any RIFLE criterion.
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(including 498 redos), reported postoperative AKI
incidence of 21.6% following redo CABG. That study
also identified redo CABG as an independent predictor of
postoperative AKI, although it did not address the impact
of AKI on survival. It is worth noting that Bove and
colleagues reported a higher incidence of AKI compared
with our results despite the fact that their definition of
AKI was stricter and based on a 100% increase in SCr,
compared with the 50% increase defined by the RIFLE
criteria.
There is little in the literature on the long-term outcome
of redo CAB surgery and its association with postoperative
AKI. The impact of postoperative AKI on long-term
survival in patients undergoing redo CABG was another
key funding of our present study. In a small study of 82
patients (with 11 reoperations) evaluating long-term
prognosis in patients requiring renal replacement therapy
postsurgery, Srivastava and colleagues22 reported survival
rates of 54% at 5 years and 38% at 7 years. Another study
of 739 elderly patients undergoing redo CABG found an
in-hospital mortality rate of 7.6% and actuarial survival
rates of 75% at 5 years and 49% at 10 years.23 The authors
also reported that increased in-hospital mortality was
associated with preoperative SCr value>1.6 mg/dL, but
that postoperative AKI did not appear to be an independent
risk factor for mortality.23 One possible explanation for
their findings is that the study was undertaken before the
advent of the RIFLE criteria, and thus was based on a
less-sensitive definition of postoperative AKI.
Additional findings of the present study are the associa-
tions between high baseline Euroscore and IABP use and
the observed 30-day mortality, as well as the associations
between baseline advanced age and CCS class 3
and all-cause long-term mortality. These findings are
confirmatory, in keeping with the outcomes reported by
previous studies.10,14
Identifying sensitive predictors of health outcomes is of
value. In the present study, the occurrence of postoperative
AKI, bedsides predicting early mortality, also predicted
postoperative ARF requiring dialysis. Indeed, 6 of 6
patients with class F AKI and 5 of 15 patients with class I
AKI subsequently developed ARF requiring dialysis,
although none of the patients with class R AKI developed
ARF requiring dialysis. In addition, our findings suggest
that the occurrence of AKI by the RIFLE criteria also
may be predictive of long-term health outcomes, although
we believe that more evidence is needed to support this
suggestion.
Predicting health outcomes with AKI by the RIFLE
criteria in patients undergoing redo CABG might lead to
changes in clinical approaches. One possible application
might be before surgery during the patient consent process,
allowing a more accurate description of the risk-to-benefit
ratio associated with the intended procedure. In addition,
the knowledge of a possible association between the
occurrence of postoperative AKI and early/long-term sur-
vival might help stimulate the development/implementation
of new clinical approaches aimed at preventing AKI. In our
series, approximately 37% of the patients were treated with
off-pump coronary surgery as an alternative surgical
technique. This approach was based on surgeon preference
in a generic attempt to reduce postoperative complications.
Whether this approach might have been beneficial or
detrimental, we cannot say, because our series did not
contain enough patients undergoing redo CABG to
ascertain the impact of this alternative technique.
This study has several limitations. First, its retrospective
design might be suggestive of residual bias and
unconsidered confounding factors. In addition, the study
represents only a relatively small cohort of patients from
a single institution. A second limitation is our lack of data
on the timing of CT angiography in relation to the date of
surgery. This might be an important factor, given that CT
angiography performed close to the time of surgery might
have acted as confounding factor in the incidence of AKI.
This lack of data was only partially addressed by our
inclusion of degree of urgency in our analysis, which can
be considered a surrogate measure of timing of CT
angiography related to time of surgery, given that urgent
patients generally undergo surgery soon after CT
angiography as part of the in-hospital urgent transfer
process. A third limitation is that our database does not
include postoperative SCr values, and thus although it was
possible to derive these values manually from the medical
records for our 380 patients in our study cohort, this was
not possible for >15,000 patients in the database
undergoing first-time CABG. This prevents us from
comparing the relationship between redo CABG surgery
and the occurrence of postoperative AKI in patients under-
going first-time CABG and those undergoing redo CABG.
A fourth limitation is a lack of prospective follow-up, which
might have prevented us from identifying additional clinical
factors occurring late after discharge that possibly
contributed to our long-term survival data. For similar
reasons, we do not have data on causes of late deaths, and
thus could not explore a long-term cause-and-effect
relationship. Finally, our patient cohort was treated over a
long period, thus possibly introducing confounding factors
owing to changes in clinical practice over time.
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